IPO News and Updates

5/23/13


LightInTheBox, a global online retail company that offers a selection of lifestyle products, announced terms for its IPO on Thursday. The Beijing, China-based company plans to raise $79 million by offering 8.3 million shares at a price range of $8.50 to $10.50. At the midpoint of the proposed range, LightInTheBox would command a market value of $465 million. LightInTheBox filed for an IPO with a proposed deal size of $86 million in April.

LightInTheBox, which was founded in 2007 and booked $236 million in sales for the 12 months ended March 31, 2013, plans to list on the NYSE under the symbol LITB. LightInTheBox initially filed confidentially on January 10, 2013. Credit Suisse and Stifel are the joint bookrunners on the deal. The deal is scheduled to price June 5.

Keywords: LITB

5/23/13


Aratana Therapeutics, which is focused on the development and commercialization of prescription medication for pets, announced terms for its IPO on Thursday. The Kansas City, KS-based company plans to raise $51 million by offering 4.3 million shares at a price range of $11 to $13. At the midpoint of the proposed range, Aratana Therapeutics would command a market value of $223 million. The company filed for an IPO with a proposed deal size of $58 million in March. 

Aratana Therapeutics, which was founded in 2010 and has yet to generate any revenue, plans to list on the NASDAQ under the symbol PETX. Stifel and Lazard Capital Markets are the joint bookrunners on the deal.

Keywords: PETX

5/23/13


Noodles & Company, which operates over 300 fast-casual restaurants serving pasta bowls inspired by regional and worldwide cuisine, filed on Thursday with the SEC to raise up to $75 million in an initial public offering.

The Broomfield, CO-based company, which was founded in 1995 and booked $312 million in sales for the 12 months ended April 2, 2013, plans to list under the symbol NDLS. The company has not yet chosen an exchange. Noodles & Company initially filed confidentially on March 22, 2013. Morgan Stanley and UBS Investment Bank are the joint bookrunners on the deal. No pricing terms were disclosed.

Keywords: NDLS

5/23/13


Constellium, an Apollo/Rio Tinto-backed manufacturer of semi-fabricated aluminum products, raised $333 million by offering 22.2 million shares (40% from selling shareholders) at $15, below the range of $17 to $19. The deal size was originally expected to be 50% from selling shareholders. Constellium plans to list on the NYSE under the symbol CSTM. Goldman Sachs, Deutsche Bank and J.P. Morgan were the top underwriters on the deal.

Keywords: CSTM

Archived News Headlines
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital, Greenwich, CT (www.renaissancecapital.com).
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital and/or the Global IPO Fund (symbol: IPOSX) may have investments in securities of companies mentioned.